FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949129416> ?p ?o ?g. }

• W2949129416 endingPage "584" @default.
• W2949129416 startingPage "573" @default.
• W2949129416 abstract "Methoxy-poly(ethylene glycol)-b-poly(ε-caprolactone) (mPEG-PCL) polymeric micelles (PMs) open a promising avenue through which ocular drug delivery with superior efficacy and tolerability can be potentially obtained. Methazolamide (MTZ) is an anti-glaucoma drug exhibiting poor corneal penetration, making it an ideal candidate for new polymeric micellar systems. MTZ-PMs were prepared using the thin film hydration procedure and optimized using a Design of Experiment (DoE) approach. In vitro drug release, thermal analyses and FT-IR characterization were also evaluated. MTT assay and histopathological assessment were carried out to verify ocular tolerability as well as Draize irritancy test. In vivo studies were conducted on rabbits to evaluate anti-glaucoma activity in a glucocorticoid-induced glaucoma model. The results showed successful entrapment of MTZ inside PMs matrix as reflected by the complete vanishing of drug melting peak in DSC thermogram and the possible formation of hydrogen bonding between MTZ and mPEG-PCL copolymer in FT-IR spectrum. The selected formula exhibited a particle size of 60 nm, entrapment efficiency of 93% and discrete spherical particles. Moreover, sustained release of MTZ, cellular and tissue biocompatibility and marked anti-glaucoma efficacy, as compared to MTZ solution, were realized. The combined results show that PMs could potentiate the therapeutic outcome of nanotechnology ocular drug delivery." @default.
• W2949129416 created "2019-06-27" @default.
• W2949129416 creator A5025380337 @default.
• W2949129416 creator A5025797697 @default.
• W2949129416 creator A5062463456 @default.
• W2949129416 creator A5067200320 @default.
• W2949129416 creator A5076642853 @default.
• W2949129416 date "2019-07-01" @default.
• W2949129416 modified "2023-10-06" @default.
• W2949129416 title "Exploring optimized methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) crystalline cored micelles in anti-glaucoma pharmacotherapy" @default.
• W2949129416 cites W1535005981 @default.
• W2949129416 cites W1672208723 @default.
• W2949129416 cites W171574099 @default.
• W2949129416 cites W1964012010 @default.
• W2949129416 cites W1985522071 @default.
• W2949129416 cites W1985631236 @default.
• W2949129416 cites W1991649944 @default.
• W2949129416 cites W1997409302 @default.
• W2949129416 cites W1997723307 @default.
• W2949129416 cites W2005668670 @default.
• W2949129416 cites W2014325374 @default.
• W2949129416 cites W2016740531 @default.
• W2949129416 cites W2017700229 @default.
• W2949129416 cites W2017754775 @default.
• W2949129416 cites W2034910778 @default.
• W2949129416 cites W2044407596 @default.
• W2949129416 cites W2050323177 @default.
• W2949129416 cites W2053862331 @default.
• W2949129416 cites W2060568174 @default.
• W2949129416 cites W2060956846 @default.
• W2949129416 cites W2061887389 @default.
• W2949129416 cites W2064849125 @default.
• W2949129416 cites W2071215562 @default.
• W2949129416 cites W2077912787 @default.
• W2949129416 cites W2084872267 @default.
• W2949129416 cites W2121646760 @default.
• W2949129416 cites W2127204539 @default.
• W2949129416 cites W2130939609 @default.
• W2949129416 cites W2134966959 @default.
• W2949129416 cites W2138170976 @default.
• W2949129416 cites W2139516405 @default.
• W2949129416 cites W2140502432 @default.
• W2949129416 cites W2158321280 @default.
• W2949129416 cites W2159599032 @default.
• W2949129416 cites W2160605010 @default.
• W2949129416 cites W2165137027 @default.
• W2949129416 cites W2171384411 @default.
• W2949129416 cites W2256979343 @default.
• W2949129416 cites W2288324932 @default.
• W2949129416 cites W2392684961 @default.
• W2949129416 cites W2432113050 @default.
• W2949129416 cites W2592201121 @default.
• W2949129416 cites W2609303274 @default.
• W2949129416 cites W2628274702 @default.
• W2949129416 cites W2742888258 @default.
• W2949129416 cites W2790708998 @default.
• W2949129416 cites W2791703856 @default.
• W2949129416 cites W2792337208 @default.
• W2949129416 cites W2794875197 @default.
• W2949129416 cites W2802638068 @default.
• W2949129416 cites W2860771669 @default.
• W2949129416 cites W2910545835 @default.
• W2949129416 cites W3020874473 @default.
• W2949129416 cites W37222647 @default.
• W2949129416 cites W4232572414 @default.
• W2949129416 doi "https://doi.org/10.1016/j.ijpharm.2019.06.011" @default.
• W2949129416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31176850" @default.
• W2949129416 hasPublicationYear "2019" @default.
• W2949129416 type Work @default.
• W2949129416 sameAs 2949129416 @default.
• W2949129416 citedByCount "32" @default.
• W2949129416 countsByYear W29491294162019 @default.
• W2949129416 countsByYear W29491294162020 @default.
• W2949129416 countsByYear W29491294162021 @default.
• W2949129416 countsByYear W29491294162022 @default.
• W2949129416 countsByYear W29491294162023 @default.
• W2949129416 crossrefType "journal-article" @default.
• W2949129416 hasAuthorship W2949129416A5025380337 @default.
• W2949129416 hasAuthorship W2949129416A5025797697 @default.
• W2949129416 hasAuthorship W2949129416A5062463456 @default.
• W2949129416 hasAuthorship W2949129416A5067200320 @default.
• W2949129416 hasAuthorship W2949129416A5076642853 @default.
• W2949129416 hasConcept C136229726 @default.
• W2949129416 hasConcept C150903083 @default.
• W2949129416 hasConcept C15920480 @default.
• W2949129416 hasConcept C178790620 @default.
• W2949129416 hasConcept C185592680 @default.
• W2949129416 hasConcept C192562407 @default.
• W2949129416 hasConcept C197934379 @default.
• W2949129416 hasConcept C207001950 @default.
• W2949129416 hasConcept C2777230088 @default.
• W2949129416 hasConcept C2777516009 @default.
• W2949129416 hasConcept C2778375690 @default.
• W2949129416 hasConcept C2779820397 @default.
• W2949129416 hasConcept C2781111393 @default.
• W2949129416 hasConcept C521977710 @default.
• W2949129416 hasConcept C71924100 @default.
• W2949129416 hasConcept C86803240 @default.

• next